Tivity Health (NASDAQ:TVTY) Lifted to “Hold” at BidaskClub

BidaskClub upgraded shares of Tivity Health (NASDAQ:TVTY) from a sell rating to a hold rating in a research note issued to investors on Wednesday, BidAskClub reports.

Several other research firms have also recently commented on TVTY. Oppenheimer started coverage on Alcon in a research note on Thursday, May 9th. They set an outperform rating and a $69.00 target price for the company. Barrington Research set a $5.00 target price on U.S. Auto Parts Network and gave the stock a buy rating in a research note on Friday, May 10th. Craig Hallum started coverage on Tivity Health in a research note on Thursday, April 11th. They set a buy rating and a $30.00 target price for the company. Zacks Investment Research cut Hess Midstream Partners from a hold rating to a sell rating in a research note on Tuesday, May 14th. Finally, Piper Jaffray Companies raised their target price on Beigene to $180.00 and gave the stock an overweight rating in a research note on Thursday, May 9th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and eight have given a buy rating to the company’s stock. Tivity Health has a consensus rating of Buy and an average target price of $33.00.

NASDAQ TVTY opened at $15.84 on Wednesday. The business’s 50 day simple moving average is $17.42. Tivity Health has a one year low of $15.83 and a one year high of $41.46. The firm has a market capitalization of $796.63 million, a PE ratio of 6.77, a P/E/G ratio of 0.69 and a beta of 1.05. The company has a quick ratio of 0.71, a current ratio of 0.86 and a debt-to-equity ratio of 2.13.

Tivity Health (NASDAQ:TVTY) last released its earnings results on Wednesday, May 8th. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.50 by $0.01. Tivity Health had a return on equity of 26.02% and a net margin of 12.18%. The business had revenue of $214.10 million during the quarter, compared to analysts’ expectations of $200.39 million. During the same quarter last year, the firm posted $0.49 earnings per share. The firm’s revenue was up 42.8% on a year-over-year basis. As a group, sell-side analysts predict that Tivity Health will post 2.35 earnings per share for the current year.

Several hedge funds have recently bought and sold shares of TVTY. Marshall Wace LLP lifted its holdings in shares of Tivity Health by 247.4% in the first quarter. Marshall Wace LLP now owns 1,600,611 shares of the company’s stock valued at $28,107,000 after purchasing an additional 1,139,877 shares in the last quarter. Wells Fargo & Company MN lifted its holdings in shares of Tivity Health by 66.0% in the first quarter. Wells Fargo & Company MN now owns 1,714,230 shares of the company’s stock valued at $30,103,000 after purchasing an additional 681,573 shares in the last quarter. Millennium Management LLC lifted its holdings in shares of Tivity Health by 291.6% in the fourth quarter. Millennium Management LLC now owns 867,656 shares of the company’s stock valued at $21,527,000 after purchasing an additional 646,096 shares in the last quarter. Handelsbanken Fonder AB lifted its holdings in shares of Tivity Health by 190.5% in the first quarter. Handelsbanken Fonder AB now owns 850,000 shares of the company’s stock valued at $14,926,000 after purchasing an additional 557,428 shares in the last quarter. Finally, Norges Bank bought a new position in shares of Tivity Health in the fourth quarter valued at approximately $12,171,000.

About Tivity Health

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Featured Story: What is the market perform rating?

Analyst Recommendations for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.